Coronary Microvascular Disease clinical trials at UCLA
1 in progress, 0 open to eligible people
Sorry, accepting new patients by invitation only
This study aims to evaluate the effects of cardiotoxic cancer therapies on myocardial blood flow (MBF) and perfusion in a prospective sample of VA patients.
Los Angeles, California
Our lead scientists for Coronary Microvascular Disease research studies include Rene Packard, MD, PhD.